https://www.globenewswire.com/news-release/2016/12/15/1087705/0/en/RespireRx-Pharmaceuticals-Inc-Announces-Data-for-CX1739-Clinical-Study-in-Opioid-Induced-Respiratory-Depression.html
RespireRx Pharmaceuticals Inc. Announces Data for CX1739
GLEN ROCK, NJ--(Marketwired - Dec 15, 2016) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (
respirerx pharmaceuticalsincannouncesdatacx1739